Intelligence Β· Clinical Pipeline

Pfizer Pipeline

All ClinicalTrials.gov programs at Pfizer β€” phase, modality, and trial IDs.

Programs
58

Quick answer

Pfizer has 58 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. gabapentin

    Pfizer

    Epilepsies, Partial

    phase 3 small molecule completed

    1 trial
  2. inotuzumab ozogamicin

    Pfizer

    Lymphoma, Follicular

    phase 3 small molecule terminated

    1 trial
  3. olmesartan alone or in combination with hydrochlorothiazide

    Pfizer

    Essential Hypertension

    phase 3 small molecule completed

    1 trial
  4. pegaptanib sodium

    Pfizer

    Macular Degeneration

    phase 3 small molecule completed

    1 trial
  5. placebo

    Pfizer

    Schizophrenia

    phase 3 small molecule terminated

    1 trial
  6. pregabalin

    Pfizer

    Partial Seizures

    phase 3 small molecule completed

    2 trials
  7. pregabalin

    Pfizer

    Neuropathy

    phase 3 small molecule terminated

    1 trial
  8. sildenafil

    Pfizer

    Hypertension, Pulmonary

    phase 3 small molecule completed

    1 trial
  9. sunitinib malate

    Pfizer

    Carcinoma, Hepatocellular

    phase 3 small molecule terminated

    1 trial
  10. talazoparib plus enzalutamide

    Pfizer

    Prostate Cancer

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many pipeline programs does Pfizer have?

58 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs